Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children



Título del documento: Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children
Revista: The brazilian journal of infectious diseases
Base de datos: PERIÓDICA
Número de sistema: 000290838
ISSN: 1413-8670
Autores: 1
2



3
Instituciones: 1Universidade de Sao Paulo, Departamento de Obstetricia e Ginecologia, Ribeirao Preto, Sao Paulo. Brasil
2Universidade de Sao Paulo, Hospital das Clinicas, Ribeirao Preto, Sao Paulo. Brasil
3Universidade de Sao Paulo, Departamento de Medicina Interna, Ribeirao Preto, Sao Paulo. Brasil
Año:
Periodo: Abr
Volumen: 8
Número: 2
Paginación: 140-150
País: Brasil
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Caso clínico
Resumen en inglés Women have emerged as the fastest growing human immunodeficiency virus (HIV) infected population worldwide, mainly because of the increasing occurrence of heterosexual transmission. Most infected women are of reproductive age and one of the greatest concerns for both women and their physicians is that more than 1,600 infants become infected with HIV each day. Almost all infections are a result of mother-to-child transmission of HIV. With the advent of combination antiretroviral therapies, transmission rates lower than 2% have been achieved in clinical studies. Antiretroviral compounds differ from most other new pharmaceutical agents in that they have become widely prescribed in pregnancy in the absence of proof of safety. We reviewed antiretroviral agents used in pregnant women infected with human immunodeficiency virus, mother-to-child transmission, and their consequences for infants
Disciplinas: Biología,
Medicina
Palabras clave: Inmunología,
Virus,
Farmacología,
VIH-1,
Infantes,
Antirretrovirales
Keyword: Biology,
Medicine,
Immunology,
Virus,
Pharmacology,
HIV-1,
Infants,
Antiretrovirals
Texto completo: Texto completo (Ver HTML)